Sentences with phrase «trial research group»

Adolescents with diabetes are at increased risk for eating disorders and disturbed eating behavior because the diabetes regimen sets in motion a pattern of dietary restraint (Marcus & Wing, 1990), and because intensive insulin therapy has been associated with weight gain (Diabetes Control and Complications Trial Research Group, 1988).
Poor adherence can result in poor metabolic control, which places the individual at risk for a host of medical complications (Diabetes Control & Complications Trial Research Group, 1993, 1994).

Not exact matches

Research reported by the NPD Group finds that trial is the primary factor in behavioral changes about beauty and new product purchases.
After the intense opposition from various farmers and consumers groups, including the uprooting of the clandestine field trial in Camarines Sur, the International Rice Research Institute (IRRI) postponed the commercialization, citing the failure of Golden Rice to produce better yields.
There is also a lot of information on the internet about baby bedding safety, about trials and testing carried out by independent research groups on certain items, and about possible dangers (including Sudden Infant Death Syndrome) associated with some baby bedding products.
Other difficulties when conducting or evaluating research in this area include ensuring the equivalency of the control and experimental groups in randomized controlled trials (RCTs), 10 controlling for participant attrition (which may affect the validity of findings by reducing group equivalence) and missed visits (which may affect validity by reducing program intensity), 11 documenting that the program was fully and accurately implemented, and determining whether the program's theory of change logically connects program activities with intended outcomes.
The groups — New York Public Interest Research Group, Reinvent Albany, Common Cause, Citizens Union and the League of Women Voters — said evidence and testimony during the trial «revealed stunning failures in New York's ethics oversight system.»
Blair Horner with the New York Public Interest Research Group said if past corruption trials are any indication, there will be plenty of unflattering testimony about the inner workings of Cuomo's government.
«Depending on what happens in the trials, the corruption parade could drive the session,» said Blair Horner, a longtime state government watchdog with the New York Public Interest Research Group.
Good - government champion Blair Horner, executive director of the New York Public Interest Research Group, says the trial's consequence on Cuomo's political futures depends on what Cuomo does going forward.
Blair Horner, with the New York Public Interest Research Group, says if past corruption trials are any indication, there will be plenty of unflattering testimony about the inner workings of Cuomo's government.
«Percoco's trial spotlighted a state government riddled with pay to play, influence peddling and unethical behavior,» said the groups that included the New York Public Interest Research Group and Common Cause.
«Albany stays on trial,» said Blair Horner, executive director of the New York Public Interest Research Group.
Blair Horner, the executive director of the New York Public Interest Research Group, said that the case had, like previous corruption trials of Albany leaders and officials, raised «troubling questions,» about the State Capitol.
While the reform alliance provided data showing trial lawyers» campaign contributions were tops among influence blocs, the New York Public Interest Research Group put teacher unions far in the lead in combined lobbying and campaign donations.
In light of the results, the CNIO Breast Cancer Clinical Research Unit has already launched a large - scale Phase II Clinical Trial to validate the results in a large group of patients.
This process, which will be the focus of much of the group's forthcoming research, will necessarily involve extensive trials.
June is not surprised that a Chinese group would jump out in front on a trial such as this: «China places a high priority on biomedical research,» he says.
Another problem is that modeling studies, like this one, are inherently less powerful than other kinds of medical research: randomized clinical trials, the gold standard in medical research, in which patients are randomly assigned different treatments or no treatment; case - control studies, which compare patients who have a condition with those who do not; or cohort studies, which determine the risk of contracting a disease by studying a group of people with similar demographics.
We urge the adoption of policies that ensure opportunities for people to participate in research studies and clinical trials without fear that the information generated by their participation will be inappropriately disclosed and adversely affect their health insurance status or that of their families, either as individuals or as members of a particular group.
Research groups at universities and hospitals need to meet strict safety guidelines for clinical trials but some small private clinics are offering therapies to people without research or marketing aResearch groups at universities and hospitals need to meet strict safety guidelines for clinical trials but some small private clinics are offering therapies to people without research or marketing aresearch or marketing approval.
The future challenges of this line of research, started through an undergraduate degree final project by Carlos Aguado in the Grupo de Computación Evolutiva y Redes Neuronales (EVANNAI - Evolutionary Computation and Neural Networks Group) at UC3M, include carrying out clinical trials using this technology, in addition to developing programs that help rehabilitate the other four movement of the shoulder: flexing, extension, internal rotation and external rotation.
University of Calgary researchers including Luchman, Weiss and Dr. Greg Cairncross — director of SACRI, and leader of the Terry Fox Research Institute (TFRI) «Therapeutic Targeting of Glioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with gliobResearch Institute (TFRI) «Therapeutic Targeting of Glioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with gliobresearch program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblastoma.
Principal investigator E. Shelley Hwang, M.D., chief of breast surgery at the Duke Cancer Institute and vice chair of research in the Duke University Department of Surgery, will lead the study through the cooperative group, The Alliance for Clinical Trials in Oncology.
Initial results were announced from the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, a multi-center prospectively conducted trial of more than 10,000 women with early stage breast cancer sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health, Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, a multi-center prospectively conducted trial of more than 10,000 women with early stage breast cancer sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health, trial of more than 10,000 women with early stage breast cancer sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health, Inc..
A research group at the Sahlgrenska Academy has now analyzed data from clinical trials and can rebut this theory.
In order to examine the «placebo breaking the blind» theory, a research group at the Sahlgrenska Academy in Gothenburg, Sweden, has now analyzed data from the clinical trials that were once undertaken to establish the antidepressant efficacy of two of the most commonly used SSRIs, paroxetine and citalopram.
When Richard Kravitz, co-vice chair of research in the department of internal medicine at the University of California, Davis, does focus groups to see what doctors think about N of 1 trials, he usually has to start by explaining what an N of 1 trial is.
In collaboration with the University College London (UCL) Cancer Trials Centre and the UCL Cancer Institute, Swanton's research group will be following about 850 patients with NSCLC from diagnosis to death as part of a clinical trial to understand tumor evolution.
The research team conducted a randomized controlled trial in 14 health centers in New York City, and compared the birth outcomes of women who received CenteringPregnancy Plus group prenatal care to those who received traditional individual care.
For the new trial, Dondorp and White gathered a group of collaborators at 11 research centers in nine African countries.
This study is part of Phase one of the RECOVER Program, a multi-phase project, involving 10 intensive care units across Canada, co-led by Drs. Margaret Herridge, Scientist at the Toronto General Research Institute, and Cameron, in collaboration with the Canadian Critical Care Trials Group.
A large group of government researchers from the Centre for Ecology and Hydrology in Merlewood, Rothamsted Research, and the Scottish Crop Research Institute designed a trial that would pit three GM crops against conventional counterparts in some 60 fields across the country.
«Continued development and clinical trials in particular are laborious and expensive, which we as a research group can not afford,» says the ETH professor.
To test the effectiveness of magnesium sulfate, the Magpie Trial Collaborative Group, a research team of scientif
In order to examine the «placebo breaking the blind» theory, a research group at the Sahlgrenska Academy, has now analyzed data from the clinical trials that were once undertaken to establish the antidepressant efficacy of two of the most commonly used SSRIs, paroxetine and citalopram.
The four combination trials that will be featured at ASCO are sponsored and managed in partnership with another nonprofit group, Ludwig Institute for Cancer Research.
In addition, University of Chicago doctors hold leadership positions in two national cooperative clinical oncology research groups — the American College of Surgeons Oncology Group (ACOSOG) and the Alliance for Clinical Trials in Oncology.
According to Col Jerome Kim, Walter Reed Army Institute of Research, US, who was also part of the lead group for the study, apart from the current four doses of vaccines that were given to subjects in the phase III clinical trials in Thailand, they are planning to give a booster does after six months to increase the strength of the vaccine.
Based on our findings, the occurrence of cancer is much higher in adults over 75 years of age compared with the proportion of patients in this age group who enroll in clinical trials,» said lead study author Bindu Kanapuru, MD, medical officer in the Division of Hematology Products, Office of Hematology and Oncology Products in the US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research, who presented the results at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9 — 12 in Atlanta.
Previous research (the Gynecologic Oncology Group's GOG181B trial) has suggested that trastuzumab is inactive in HER2 / neu - expressing endometrial carcinomas, and in the current study, nearly half of the participants «ultimately did not have tumoral HER2 / neu gene amplification,» Dr. Santin said.
The latest data, the result of the largest long - term follow - up study of autism treatment yet undertaken, is from a randomised controlled trial by three UK research groups and published in The Lancet.
The research group conducted high throughput screening of over 1000 compounds consisting of existing drugs, including those approved by the Food and Drug Administration (FDA) of USA, Europe or Asia, and drugs under clinical trial, to search for drugs that can regulate the circadian rhythm in mammals.
2) Sharing of data from clinical trials and research integrity Presenter: Karmela Krleza - Jeric, University of Ottawa, Croatian Medical Journal, and Ottawa Group, Canada
An international research team, led by University College London's Professor Jonathan Ledermann, carried out a trial to see whether olaparib could have a role to play in preventing ovarian cancer from coming back in this group of patients.
Before beginning, trials should be carefully reviewed by a group of people who together have broad expertise and experience in research, medicine and ethics.
The international early Phase II trial led by a team based at the Oxford Cancer Research Centre will trial the experimental drug called LY2181308 with advanced non-small cell lung cancer patients who no longer respond to platinum chemotherapy - the standard initial treatment for this group.
The Focus on Cancer blog discusses a variety of cancer - related topics, including treatment advances, research efforts and clinical trials, nutrition, support groups, survivorship and patient stories.
Dr. Falk is also PI of an NIH, pharma, and philanthropic funded translational research laboratory group at CHOP that investigates the causes and global metabolic consequences of mitochondrial disease, as well as targeted therapies, in C. elegans, zebrafish, mouse, and human tissue models of genetic - based respiratory chain dysfunction, and directs multiple clinical treatment trials in mitochondrial disease patients.
Results: A total of 43 terms are included in the glossary, grouped into five main themes -(i) mechanisms of decision, (ii) characteristics of molecular alterations, (iii) tumour characteristics, (iv) clinical trials and statistics and (v) new research tools.
a b c d e f g h i j k l m n o p q r s t u v w x y z